Paul A. Hattis

Associate professor, Tufts University Medical School

Stories by Paul A. Hattis

With COVID surging again, Dr. Lee returns

Maybe we need a right to repair for hospital equipment

Reading between the lines at cost trend hearing

Baker, Healey remarks hint at broader market concerns

Four issues to watch on health insurance

Premiums rising but uninsured ranks hold steady

HPC: Health care spending to fall 10% in Mass.

Decline leaves time for more focus on policy, equity

Juneteenth discussion at Tufts misses elephant in room

Higher ed financing system another form of structural racism

The black swan of our time

COVID causing cracks in health care system to widen

Fewer, but sicker patients in the MGH ICUs

Transfers from other hospitals driving greater acuity

At MGH, they worry about a second surge

‘We are at a very dangerous point,’ Dr. Lee says

I’m seeing promising ventilator death data

Dr. Lee says ICU patients still face tough recoveries

Examining COVID-19 gender differences

Men more likely to die, so why not in Massachusetts?

Dr. Lee: We’re busy but in good shape

Concerns remain with pain sedatives, ventilators

Surge still manageable for Dr. Lee

Heart complications; intravenous drug supply concerns

Dr. Lee: Preparing for the surge

Concerns on staff, PPE, but testing improving

2 takes on how to protect our health and democracy

Gathering nominating signatures in the coronavirus era

MGH doc Jarone Lee: We’re seeing patients of all ages

'We are at the beginning of an exponential growth phase’

Stepping up on coronavirus treatment coverage

Self-insured employers, feds need to do their part

I’ve got questions on Rep. Neal, Partners

Why did congressman buckle? Is outpatient expansion good for us?

Money for nothing

The wacky world of hospital reimbursement

What consumers deserve from Harvard Pilgrim-Tufts merger

Real cost savings and payment system innovation should be expected

Medicare for All interim steps

Focus for now on should be on market dysfunction issues

MassBIO’s drug pricing concerns don’t add up

Big pharma should stop making threats about leaving

Time for Tufts soul-searching on Purdue Pharma

Whatever probe uncovers should be released publicly

A pitch for socializing corporate health insurance premiums

High-salaried workers may need to pay more so lower-wage workers pay less

Partners is like a shark – always on the move

Let’s examine its growth strategies going forward